Perfil
Dr. Marco Verwijs is an Executive Vice President-Technical Operations at CervoMed, Inc. Dr. Verwijs was previously employed as a Chief Technical Officer by Aerovate Therapeutics, Inc., a Chief Technical Officer by Adipo Therapeutics LLC, and a Chief Technology Officer by Aerovate Therapeutics, Inc. He received his graduate degree from Delft University of Technology and a doctorate degree from the University of Florida.
Cargos activos de Marco Verwijs
| Empresas | Cargo | Inicio |
|---|---|---|
| CERVOMED INC. | Director Técnico/Científico/I+D | 01/06/2025 |
Antiguos cargos conocidos de Marco Verwijs.
| Empresas | Cargo | Fin |
|---|---|---|
| JADE BIOSCIENCES, INC. | Director Técnico/Científico/I+D | 01/07/2024 |
| JADE BIOSCIENCES, INC. | Director Técnico/Científico/I+D | - |
Adipo Therapeutics LLC
Adipo Therapeutics LLC Pharmaceuticals: MajorHealth Technology Develops polymer-based, notch-inhibiting nanoparticles that are injected directly into adipose (fat) tissue | Director Técnico/Científico/I+D | - |
Formación de Marco Verwijs.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 5 |
|---|---|
University of Florida
University of Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Delft University of Technology
Delft University of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aerovate Therapeutics, Inc.
Aerovate Therapeutics, Inc. BiotechnologyHealth Technology Provides gene therapy services | Health Technology |
Adipo Therapeutics LLC
Adipo Therapeutics LLC Pharmaceuticals: MajorHealth Technology Develops polymer-based, notch-inhibiting nanoparticles that are injected directly into adipose (fat) tissue | Health Technology |
CervoMed, Inc.
CervoMed, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company that develops novel therapies | Commercial Services |
- Bolsa de valores
- Insiders
- Marco Verwijs
















